A50 - Congenital syphilis——
A50.1 - Early congenital syphilis, latent——
A50.4 - Late congenital neurosyphilis [juvenile neurosyphilis]——
A50.40 - Late congenital neurosyphilis, unspecified——
A50.49 - Other late congenital neurosyphilis——
A50.6 - Late congenital syphilis, latent——
A50.7 - Late congenital syphilis, unspecified——
A50.9 - Congenital syphilis, unspecified——
A51 - Early syphilis——
A51.0 - Primary genital syphilis——
A51.3 - Secondary syphilis of skin and mucous membranes——
A51.32 - Syphilitic alopecia——
A51.39 - Other secondary syphilis of skin——
A51.4 - Other secondary syphilis——
A51.41 - Secondary syphilitic meningitis——
A51.42 - Secondary syphilitic female pelvic disease——
A51.49 - Other secondary syphilitic conditions——
A51.5 - Early syphilis, latent——
A52 - Late syphilis——
A52.1 - Symptomatic neurosyphilis——
A52.10 - Symptomatic neurosyphilis, unspecified——
A52.19 - Other symptomatic neurosyphilis——
A52.3 - Neurosyphilis, unspecified——
A52.7 - Other symptomatic late syphilis——
A52.79 - Other symptomatic late syphilis——
A52.8 - Late syphilis, latent——
A53 - Other and unspecified syphilis——
A53.0 - Latent syphilis, unspecified as early or late——
A53.9 - Syphilis, unspecified——
A54 - Gonococcal infection——
A56 - Other sexually transmitted chlamydial diseases——
A56.11 - Chlamydial female pelvic inflammatory disease——
A56.8 - Sexually transmitted chlamydial infection of other sites——
A60 - Anogenital herpesviral [herpes simplex] infections——
A60.0 - Herpesviral infection of genitalia and urogenital tract——
A60.00 - Herpesviral infection of urogenital system, unspecified——
A60.01 - Herpesviral infection of penis——
A60.02 - Herpesviral infection of other male genital organs——
A60.03 - Herpesviral cervicitis——
A60.04 - Herpesviral vulvovaginitis——
A60.09 - Herpesviral infection of other urogenital tract——
A60.1 - Herpesviral infection of perianal skin and rectum——
A60.9 - Anogenital herpesviral infection, unspecified——
B00 - Herpesviral [herpes simplex] infections——
B00.0 - Eczema herpeticum——
B00.1 - Herpesviral vesicular dermatitis——
B00.2 - Herpesviral gingivostomatitis and pharyngotonsillitis——
B00.3 - Herpesviral meningitis——
B00.4 - Herpesviral encephalitis——
B00.5 - Herpesviral ocular disease——
B00.50 - Herpesviral ocular disease, unspecified——
B00.51 - Herpesviral iridocyclitis——
B00.52 - Herpesviral keratitis——
B00.53 - Herpesviral conjunctivitis——
B00.8 - Other forms of herpesviral infections——
B00.81 - Herpesviral hepatitis——
B00.82 - Herpes simplex myelitis——
B00.89 - Other herpesviral infection——
B00.9 - Herpesviral infection, unspecified——
B02 - Zoster [herpes zoster]——
B02.1 - Zoster meningitis——
B02.23 - Postherpetic polyneuropathy——
B02.39 - Other herpes zoster eye disease——
B10 - Other human herpesviruses——
B10.0 - Other human herpesvirus encephalitis——
B10.01 - Human herpesvirus 6 encephalitis——
B10.8 - Other human herpesvirus infection——
B10.81 - Human herpesvirus 6 infection——
B10.82 - Human herpesvirus 7 infection——
D68 - Other coagulation defects——
D68.61 - Antiphospholipid syndrome——
D68.62 - Lupus anticoagulant syndrome——
E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy——
E34.5 - Androgen insensitivity syndrome——
E71.522 - Adrenomyeloneuropathy——
F01 - Vascular dementia——
F02 - Dementia in other diseases classified elsewhere——
F03 - Unspecified dementia——
F03.9 - Unspecified dementia——
F03.90 - Unspecified dementia without behavioral disturbance——
F03.91 - Unspecified dementia with behavioral disturbance——
F06.0 - Psychotic disorder with hallucinations due to known physiological condition——
F10.27 - Alcohol dependence with alcohol-induced persisting dementia——
F18.17 - Inhalant abuse with inhalant-induced dementia——
G31.09 - Other frontotemporal dementia——
G31.83 - Dementia with Lewy bodies——
G31.84 - Mild cognitive impairment, so stated——
G58 - Other mononeuropathies——
G58.9 - Mononeuropathy, unspecified——
G60 - Hereditary and idiopathic neuropathy——
G60.0 - Hereditary motor and sensory neuropathy——
G60.3 - Idiopathic progressive neuropathy——
G60.8 - Other hereditary and idiopathic neuropathies——
G61 - Inflammatory polyneuropathy——
G61.1 - Serum neuropathy——
G62 - Other and unspecified polyneuropathies——
G62.9 - Polyneuropathy, unspecified——
G63 - Polyneuropathy in diseases classified elsewhere——
G90.0 - Idiopathic peripheral autonomic neuropathy——
G99 - Other disorders of nervous system in diseases classified elsewhere——
G99.0 - Autonomic neuropathy in diseases classified elsewhere——
I32 - Pericarditis in diseases classified elsewhere——
I39 - Endocarditis and heart valve disorders in diseases classified elsewhere——
I40 - Acute myocarditis——
I40.0 - Infective myocarditis——
I40.1 - Isolated myocarditis——
I40.8 - Other acute myocarditis——
I40.9 - Acute myocarditis, unspecified——
I41 - Myocarditis in diseases classified elsewhere——
I73 - Other peripheral vascular diseases——
I73.0 - Raynaud's syndrome——
I73.00 - Raynaud's syndrome without gangrene——
I73.01 - Raynaud's syndrome with gangrene——
J39 - Other diseases of upper respiratory tract——
J99 - Respiratory disorders in diseases classified elsewhere——
K12 - Stomatitis and related lesions——
L03.314 - Cellulitis of groin——
L03.81 - Cellulitis of other sites——
L03.90 - Cellulitis, unspecified——
L63 - Alopecia areata——
L63.0 - Alopecia (capitis) totalis——
L63.1 - Alopecia universalis——
L63.8 - Other alopecia areata——
L63.9 - Alopecia areata, unspecified——
L64 - Androgenic alopecia——
L64.0 - Drug-induced androgenic alopecia——
L64.8 - Other androgenic alopecia——
L64.9 - Androgenic alopecia, unspecified——
L65 - Other nonscarring hair loss——
L65.2 - Alopecia mucinosa——
L66 - Cicatricial alopecia [scarring hair loss]——
L66.8 - Other cicatricial alopecia——
L66.9 - Cicatricial alopecia, unspecified——
L93 - Lupus erythematosus——
L93.0 - Discoid lupus erythematosus——
L93.1 - Subacute cutaneous lupus erythematosus——
L93.2 - Other local lupus erythematosus——
M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis——
M32 - Systemic lupus erythematosus (SLE)——
M32.0 - Drug-induced systemic lupus erythematosus——
M32.10 - Systemic lupus erythematosus, organ or system involvement unspecified——
M32.8 - Other forms of systemic lupus erythematosus——
M32.9 - Systemic lupus erythematosus, unspecified——
N08 - Glomerular disorders in diseases classified elsewhere——
N16 - Renal tubulo-interstitial disorders in diseases classified elsewhere——
N70 - Salpingitis and oophoritis——
N72 - Inflammatory disease of cervix uteri——
N73 - Other female pelvic inflammatory diseases——
N73.0 - Acute parametritis and pelvic cellulitis——
N73.3 - Female acute pelvic peritonitis——
N73.9 - Female pelvic inflammatory disease, unspecified——
N74 - Female pelvic inflammatory disorders in diseases classified elsewhere——
N77 - Vulvovaginal ulceration and inflammation in diseases classified elsewhere——
N88 - Other noninflammatory disorders of cervix uteri——
N89 - Other noninflammatory disorders of vagina——
N90 - Other noninflammatory disorders of vulva and perineum——
N98.3 - Complications of attempted introduction of embryo in embryo transfer——
O09 - Supervision of high risk pregnancy——
O23.9 - Unspecified genitourinary tract infection in pregnancy——
O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester——
O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester——
O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester——
O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester——
O26 - Maternal care for other conditions predominantly related to pregnancy——
O26.4 - Herpes gestationis——
O36.01 - Maternal care for anti-D [Rh] antibodies——
O86.2 - Urinary tract infection following delivery——
O98 - Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium——
O98.1 - Syphilis complicating pregnancy, childbirth and the puerperium——
O98.51 - Other viral diseases complicating pregnancy——
O98.52 - Other viral diseases complicating childbirth——
O98.53 - Other viral diseases complicating the puerperium——
O99.01 - Anemia complicating pregnancy——
O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester——
O99.810 - Abnormal glucose complicating pregnancy——
O99.814 - Abnormal glucose complicating childbirth——
O99.830 - Other infection carrier state complicating pregnancy——
O9A.41 - Sexual abuse complicating pregnancy——
O9A.42 - Sexual abuse complicating childbirth——
P35.2 - Congenital herpesviral [herpes simplex] infection——
Q84.0 - Congenital alopecia——
R41 - Other symptoms and signs involving cognitive functions and awareness——
R43.0 - Anosmia——
R44.3 - Hallucinations, unspecified——
R50 - Fever of other and unknown origin——
R50.9 - Fever, unspecified——
T74.2 - Sexual abuse, confirmed——
T74.21 - Adult sexual abuse, confirmed——
T74.21XA - Adult sexual abuse, confirmed, initial encounter——
T74.22 - Child sexual abuse, confirmed——
T76.2 - Sexual abuse, suspected——
T76.21 - Adult sexual abuse, suspected——
T76.21XA - Adult sexual abuse, suspected, initial encounter——
T76.21XD - Adult sexual abuse, suspected, subsequent encounter——
T76.21XS - Adult sexual abuse, suspected, sequela——
T76.22 - Child sexual abuse, suspected——
T76.22XA - Child sexual abuse, suspected, initial encounter——
T76.22XD - Child sexual abuse, suspected, subsequent encounter——
T86 - Complications of transplanted organs and tissue——
T86.4 - Complications of liver transplant——
T86.40 - Unspecified complication of liver transplant——
T86.41 - Liver transplant rejection——
T86.42 - Liver transplant failure——
T86.43 - Liver transplant infection——
T86.49 - Other complications of liver transplant——
Z04.4 - Encounter for examination and observation following alleged rape——
Z04.41 - Encounter for examination and observation following alleged adult rape——
Z04.42 - Encounter for examination and observation following alleged child rape——
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission——
Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]——
Z11.5 - Encounter for screening for other viral diseases——
Z11.51 - Encounter for screening for human papillomavirus (HPV)——
Z16 - Resistance to antimicrobial drugs——
Z16.33 - Resistance to antiviral drug(s)——
Z20 - Contact with and (suspected) exposure to communicable diseases——
Z33 - Pregnant state——
Z34 - Encounter for supervision of normal pregnancy——
Z34.0 - Encounter for supervision of normal first pregnancy——
Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester——
Z34.8 - Encounter for supervision of other normal pregnancy——
Z48.23 - Encounter for aftercare following liver transplant——
Z72.5 - High risk sexual behavior——
Z79 - Long term (current) drug therapy——
Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID)——
Z79.52 - Long term (current) use of systemic steroids——
Z79.89 - Other long term (current) drug therapy——
Z79.899 - Other long term (current) drug therapy——
Z94.4 - Liver transplant status——